The proposed $686M merger between Amag Pharmaceuticals (AMAG) and Allos Therapeutics (ALTH)...

|About: AMAG Pharmaceuticals, Inc. (AMAG)|By:, SA News Editor

The proposed $686M merger between Amag Pharmaceuticals (AMAG) and Allos Therapeutics (ALTH) could be scuttled after two large shareholders of AMAG threaten to vote against the transaction. Reports say the investors are evaluating if a management shakeup or supporting a tender offer from MSMB Capital might be better options. AMAG +8.1% premarket.